(1S,2R,3S,4R,5R)-2,3,4-trihydroxy-5-[4-[4-[2-methoxy-8-(4-methoxyphenyl)-6,11-dioxo-5-(2-trimethylsilylethoxymethyl)-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]butanoyloxymethyl]-3-prop-2-ynoxyphenoxy]cyclohexane-1-carboxylic acid

C47H56N2O14Si — CID 162009347

IUPAC(1S,2R,3S,4R,5R)-2,3,4-trihydroxy-5-[4-[4-[2-methoxy-8-(4-methoxyphenyl)-6,11-dioxo-5-(2-trimethylsilylethoxymethyl)-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]butanoyloxymethyl]-3-prop-2-ynoxyphenoxy]cyclohexane-1-carboxylic acid
SMILESC#CCOc1cc(O[C@@H]2C[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)ccc1COC(=O)CCCc1cc2c(cc1OC)C(=O)N1C=C(c3ccc(OC)cc3)CC1C(=O)N2COCC[Si](C)(C)C
InChIInChI=1S/C47H56N2O14Si/c1-7-17-61-39-22-33(63-40-24-35(47(56)57)42(51)44(53)43(40)52)16-13-30(39)26-62-41(50)10-8-9-29-20-36-34(23-38(29)59-3)45(54)48-25-31(28-11-14-32(58-2)15-12-28)21-37(48)46(55)49(36)27-60-18-19-64(4,5)6/h1,11-16,20,22-23,25,35,37,40,42-44,51-53H,8-10,17-19,21,24,26-27H2,2-6H3,(H,56,57)/t35-,37?,40+,42+,43-,44-/m0/s1
InChIKeyBZFPHUVDSARWIK-HBOFVJCFSA-N
MW901.05 g/mol
LogP4.63
Rot. Bonds19

About (1S,2R,3S,4R,5R)-2,3,4-trihydroxy-5-[4-[4-[2-methoxy-8-(4-methoxyphenyl)-6,11-dioxo-5-(2-trimethylsilylethoxymethyl)-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]butanoyloxymethyl]-3-prop-2-ynoxyphenoxy]cyclohexane-1-carboxylic acid

(1S,2R,3S,4R,5R)-2,3,4-trihydroxy-5-[4-[4-[2-methoxy-8-(4-methoxyphenyl)-6,11-dioxo-5-(2-trimethylsilylethoxymethyl)-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]butanoyloxymethyl]-3-prop-2-ynoxyphenoxy]cyclohexane-1-carboxylic acid (PubChem CID 162009347) has the molecular formula C47H56N2O14Si and a molecular weight of 901.05 g/mol. Its IUPAC name is (1S,2R,3S,4R,5R)-2,3,4-trihydroxy-5-[4-[4-[2-methoxy-8-(4-methoxyphenyl)-6,11-dioxo-5-(2-trimethylsilylethoxymethyl)-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]butanoyloxymethyl]-3-prop-2-ynoxyphenoxy]cyclohexane-1-carboxylic acid.

Molecular Properties

Compound Name(1S,2R,3S,4R,5R)-2,3,4-trihydroxy-5-[4-[4-[2-methoxy-8-(4-methoxyphenyl)-6,11-dioxo-5-(2-trimethylsilylethoxymethyl)-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]butanoyloxymethyl]-3-prop-2-ynoxyphenoxy]cyclohexane-1-carboxylic acid
PubChem CID162009347
Molecular FormulaC47H56N2O14Si
Molecular Weight901.05 g/mol
Exact Mass900.35
IUPAC Name(1S,2R,3S,4R,5R)-2,3,4-trihydroxy-5-[4-[4-[2-methoxy-8-(4-methoxyphenyl)-6,11-dioxo-5-(2-trimethylsilylethoxymethyl)-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]butanoyloxymethyl]-3-prop-2-ynoxyphenoxy]cyclohexane-1-carboxylic acid
SMILESC#CCOc1cc(O[C@@H]2C[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)ccc1COC(=O)CCCc1cc2c(cc1OC)C(=O)N1C=C(c3ccc(OC)cc3)CC1C(=O)N2COCC[Si](C)(C)C
InChIInChI=1S/C47H56N2O14Si/c1-7-17-61-39-22-33(63-40-24-35(47(56)57)42(51)44(53)43(40)52)16-13-30(39)26-62-41(50)10-8-9-29-20-36-34(23-38(29)59-3)45(54)48-25-31(28-11-14-32(58-2)15-12-28)21-37(48)46(55)49(36)27-60-18-19-64(4,5)6/h1,11-16,20,22-23,25,35,37,40,42-44,51-53H,8-10,17-19,21,24,26-27H2,2-6H3,(H,56,57)/t35-,37?,40+,42+,43-,44-/m0/s1
InChIKeyBZFPHUVDSARWIK-HBOFVJCFSA-N
XLogP4.63
TPSA211.06 Ų
H-Bond Donors4
H-Bond Acceptors13
Rotatable Bonds19
Heavy Atoms64
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500901.05
LogP ≤ 54.63
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze (1S,2R,3S,4R,5R)-2,3,4-trihydroxy-5-[4-[4-[2-methoxy-8-(4-methoxyphenyl)-6,11-dioxo-5-(2-trimethylsilylethoxymethyl)-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]butanoyloxymethyl]-3-prop-2-ynoxyphenoxy]cyclohexane-1-carboxylic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1S,2R,3S,4R,5R)-2,3,4-trihydroxy-5-[4-[4-[2-methoxy-8-(4-methoxyphenyl)-6,11-dioxo-5-(2-trimethylsilylethoxymethyl)-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]butanoyloxymethyl]-3-prop-2-ynoxyphenoxy]cyclohexane-1-carboxylic acid?
The IUPAC name of (1S,2R,3S,4R,5R)-2,3,4-trihydroxy-5-[4-[4-[2-methoxy-8-(4-methoxyphenyl)-6,11-dioxo-5-(2-trimethylsilylethoxymethyl)-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]butanoyloxymethyl]-3-prop-2-ynoxyphenoxy]cyclohexane-1-carboxylic acid (CID 162009347) is (1S,2R,3S,4R,5R)-2,3,4-trihydroxy-5-[4-[4-[2-methoxy-8-(4-methoxyphenyl)-6,11-dioxo-5-(2-trimethylsilylethoxymethyl)-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]butanoyloxymethyl]-3-prop-2-ynoxyphenoxy]cyclohexane-1-carboxylic acid.
What is the SMILES notation for (1S,2R,3S,4R,5R)-2,3,4-trihydroxy-5-[4-[4-[2-methoxy-8-(4-methoxyphenyl)-6,11-dioxo-5-(2-trimethylsilylethoxymethyl)-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]butanoyloxymethyl]-3-prop-2-ynoxyphenoxy]cyclohexane-1-carboxylic acid?
The canonical SMILES for (1S,2R,3S,4R,5R)-2,3,4-trihydroxy-5-[4-[4-[2-methoxy-8-(4-methoxyphenyl)-6,11-dioxo-5-(2-trimethylsilylethoxymethyl)-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]butanoyloxymethyl]-3-prop-2-ynoxyphenoxy]cyclohexane-1-carboxylic acid is C#CCOc1cc(O[C@@H]2C[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)ccc1COC(=O)CCCc1cc2c(cc1OC)C(=O)N1C=C(c3ccc(OC)cc3)CC1C(=O)N2COCC[Si](C)(C)C.
What is the InChIKey of (1S,2R,3S,4R,5R)-2,3,4-trihydroxy-5-[4-[4-[2-methoxy-8-(4-methoxyphenyl)-6,11-dioxo-5-(2-trimethylsilylethoxymethyl)-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]butanoyloxymethyl]-3-prop-2-ynoxyphenoxy]cyclohexane-1-carboxylic acid?
The InChIKey is BZFPHUVDSARWIK-HBOFVJCFSA-N. The full InChI is InChI=1S/C47H56N2O14Si/c1-7-17-61-39-22-33(63-40-24-35(47(56)57)42(51)44(53)43(40)52)16-13-30(39)26-62-41(50)10-8-9-29-20-36-34(23-38(29)59-3)45(54)48-25-31(28-11-14-32(58-2)15-12-28)21-37(48)46(55)49(36)27-60-18-19-64(4,5)6/h1,11-16,20,22-23,25,35,37,40,42-44,51-53H,8-10,17-19,21,24,26-27H2,2-6H3,(H,56,57)/t35-,37?,40+,42+,43-,44-/m0/s1.
What are the key properties of (1S,2R,3S,4R,5R)-2,3,4-trihydroxy-5-[4-[4-[2-methoxy-8-(4-methoxyphenyl)-6,11-dioxo-5-(2-trimethylsilylethoxymethyl)-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]butanoyloxymethyl]-3-prop-2-ynoxyphenoxy]cyclohexane-1-carboxylic acid?
(1S,2R,3S,4R,5R)-2,3,4-trihydroxy-5-[4-[4-[2-methoxy-8-(4-methoxyphenyl)-6,11-dioxo-5-(2-trimethylsilylethoxymethyl)-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]butanoyloxymethyl]-3-prop-2-ynoxyphenoxy]cyclohexane-1-carboxylic acid has a molecular weight of 901.05 g/mol, XLogP of 4.63, 19 rotatable bonds, 4 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for (1S,2R,3S,4R,5R)-2,3,4-trihydroxy-5-[4-[4-[2-methoxy-8-(4-methoxyphenyl)-6,11-dioxo-5-(2-trimethylsilylethoxymethyl)-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]butanoyloxymethyl]-3-prop-2-ynoxyphenoxy]cyclohexane-1-carboxylic acid is sourced from PubChem (CID 162009347), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).